Double-blind, placebo-controlled, crossover trial of propranolol as treatment for menopausal vasomotor symptoms

D. Campbell, B. Oldfield

Research output: Contribution to journalArticleResearchpeer-review

10 Citations (Scopus)


A trial of propranolol for the treatment of vasomotor symptoms was conducted among 37 menopausal women in a double-blind, placebo-controlled, crossover fashion. When compared with placebo, propranolol had a statistically significant effect on the reduction of both the frequency and severity of vasomotor symptoms (P<0.01). In selected patients, propranolol may be an alternative to the treatment of vasomotor symptoms with exogenous estrogens.

Original languageEnglish
Pages (from-to)356-364
Number of pages9
JournalClinical Therapeutics
Issue number5
Publication statusPublished - 1 Dec 1981

Cite this